What is the correct dose and frequency of epinephrine (adrenaline) administration for a pediatric patient in cardiac arrest with a history of acute kidney injury (Impaired renal function) and severe hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing in Pediatric Cardiac Arrest

Administer epinephrine 0.01 mg/kg (10 mcg/kg) IV/IO every 3-5 minutes with a maximum single dose of 1 mg, using the 1:10,000 concentration (0.1 mg/mL), regardless of acute kidney injury or hyperkalemia status. 1

Standard Dose Protocol

The dose remains 0.01 mg/kg IV/IO for all pediatric cardiac arrest patients, including those with renal impairment and hyperkalemia. 1 This translates to 0.1 mL/kg of the 1:10,000 solution (0.1 mg/mL concentration). 1

  • Maximum single dose is 1 mg regardless of patient weight 1
  • Use IV or IO routes preferentially; these provide more predictable drug levels than endotracheal administration 1
  • If endotracheal administration is necessary (no vascular access), use a higher dose of 0.1 mg/kg to compensate for reduced bioavailability 1

Dosing Frequency: Every 3-5 Minutes

Repeat epinephrine every 3-5 minutes throughout the resuscitation until return of spontaneous circulation (ROSC). 2, 1

The evidence on optimal dosing intervals is complex and somewhat contradictory:

  • Avoid dosing more frequently than every 3 minutes: Very-low-certainty evidence suggests that intervals less than 3 minutes are associated with lower 12-month survival (adjusted OR 0.50; 95% CI, 0.24-1.06) compared to 3-5 minute intervals 2
  • The 2020 International Consensus cannot make a firm recommendation about optimal subsequent dose intervals due to very low confidence in the evidence 2
  • The 3-5 minute interval represents the safest approach balancing potential benefit with avoiding harm from excessive dosing 1

Critical Timing Considerations

For nonshockable rhythms (asystole, PEA), administer the initial epinephrine dose as early in the resuscitation as possible. 2 This is a weak recommendation based on very-low-certainty evidence, but early administration is associated with improved outcomes. 2

  • For shockable rhythms (VF/pVT), no specific recommendation exists for timing of initial epinephrine 2
  • Every minute of delay in the first epinephrine dose decreases survival in nonshockable cardiac arrest 1

High-Dose Epinephrine: Contraindicated

Do not use high-dose epinephrine (0.1 mg/kg or 100 mcg/kg). 1, 3 The highest quality randomized controlled trial demonstrated that high-dose epinephrine as rescue therapy resulted in significantly worse 24-hour survival compared to standard dosing (1/34 vs 7/34 survived; odds ratio for death 8.6; P=0.05). 3

  • In asphyxial arrest specifically, high-dose epinephrine was particularly harmful: 0/12 survived at 24 hours with high-dose vs 7/18 with standard dose (P=0.02) 3
  • High-dose epinephrine does not improve return of spontaneous circulation rates 3
  • The American Academy of Pediatrics explicitly states that high-dose epinephrine is associated with reduced 24-hour survival and does not improve neurologic outcomes 1

Special Considerations for Renal Impairment and Hyperkalemia

The standard epinephrine dose does not require adjustment for acute kidney injury or hyperkalemia during cardiac arrest. The immediate life-threatening nature of cardiac arrest supersedes concerns about epinephrine's potential renal effects or exacerbation of hyperkalemia.

  • While epinephrine dosing (both total number and frequency) has been identified as a risk factor for post-arrest acute kidney injury 4, this does not justify withholding or reducing doses during active resuscitation
  • Hyperkalemia itself is a potentially reversible cause of cardiac arrest and should be treated concurrently with calcium chloride or calcium gluconate, sodium bicarbonate, and other standard therapies 1
  • The priority during cardiac arrest is achieving ROSC; renal protection strategies are secondary

Administration Technique

  • Administer during ongoing chest compressions—do not interrupt compressions for drug administration 1
  • Prepare doses in advance to minimize delays 1
  • Verify concentration before administration: confusion between 1:1,000 and 1:10,000 concentrations can be fatal 1
  • Follow each dose with a saline flush to ensure drug delivery 1

Common Pitfalls to Avoid

  • Do not dose more frequently than every 3 minutes in an attempt to improve outcomes—this may worsen survival 2, 1
  • Do not escalate to high-dose epinephrine if standard doses fail—continue standard dosing 1, 3
  • Do not delay the first dose in nonshockable rhythms while establishing "perfect" access—use IO if IV access is delayed 1
  • Do not reduce or withhold epinephrine due to concerns about renal function or hyperkalemia during active cardiac arrest—achieving ROSC is the priority

References

Guideline

Pediatric Emergency Medication Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Identifying Risk for Acute Kidney Injury in Infants and Children Following Cardiac Arrest.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.